Reduced use of bone age during Covid-19
BoneXpert use dropped to 28% of the normal level in the period 23 March – 19 April. The following four weeks it rose to 45% of the normal level.
BoneXpert use dropped to 28% of the normal level in the period 23 March – 19 April. The following four weeks it rose to 45% of the normal level.
Clínica Alemana in Santiago, Chile, has been a customer of Visiana since 2018, performing 5900 BoneXpert analyses per year. The clinic took initiative to perform an independent validation study of BoneXpert’s GP bone age assessment, and this was published in Revista chilena de pediatría:
https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0370-41062018000500606&lng=en&nrm=iso&tlng=en
RNSA (The Radiological Society of North America) organized a machine learning challenge in bone age rating in 2017. This article reviews the challenge and explains its crucial role in boosting performance of BoneXpert in terms of bone age ratings.
Read more “RSNA challenge boosts automated bone age ratings”
BoneXpert has been licensed to several major children’s hospitals in Italy, culminating with the sales to the largest children’s hospital in Europe Ospedale Pediatrico Bambino Gesù in Rome, run by the Vatican City. The number of sites having purchased a license to BoneXpert is now 135
There is a lot of talk about how artificial intelligence will affect radiology, but not much about the AI systems already in use. It is therefore timely that Radboud University and EuSoMII are organising a Hands-on AI Day in Nijmegen on April 21, 2018.
Over 100 hospitals are now using BoneXpert!
Prof Dr med Oskar Jenni of University of Zurich with expertise in developmental psychology, and PhD Hans Henrik Thodberg, developer of BoneXpert, will give a joint, interdisciplinary talk: Age estimation at the end of puberty: From a hand radiograph or from mental/psychological assessment
Read more “Special Focus Session on age assessment at ESPR 2017”
BoneXpert has been introduced in four new countries by a purchase from these institutions:
There are now in total 80 hospitals using BoneXpert for at least 100 analyses per year.
Two new papers report the use of BoneXpert to assess rheumatoid and psoriatic arthritis. They exploit the recent extension of BoneXpert’s measurement of cortical thickness in the metacarpals to adults.